Dr. Reddy's Laboratories (RDY) Earnings Date, Estimates & Call Transcripts $69.78 -0.05 (-0.07%) (As of 12/5/2023 ET) Add Compare Share Share Today's Range$69.33▼$69.9250-Day Range$64.27▼$69.9052-Week Range$51.11▼$73.17Volume163,884 shsAverage Volume241,306 shsMarket Capitalization$11.64 billionP/E Ratio18.81Dividend Yield0.59%Price Target$70.00 EarningsStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Earnings SummaryUpcoming Earnings DateJan. 24EstimatedActual EPS (Oct. 27) $1.07 Beat By $0.19 Consensus EPS (Oct. 27) $0.88 Get Dr. Reddy's Laboratories Earnings AlertsEnter your email address below to receive the latest news and earnings results for RDY and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueRDY Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.RDY Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Dr. Reddy's Laboratories Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ4 20231$0.57$0.57$0.5720231$0.57$0.57$0.57Q1 20241$0.71$0.71$0.71Q2 20241$0.88$0.88$0.88Q3 20241$0.87$0.87$0.87Q4 20241$0.86$0.86$0.86FY 20244$3.32$3.32$3.32Q1 20251$1.10$1.10$1.10Q2 20251$0.99$0.99$0.99Q3 20251$1.00$1.00$1.00Q4 20251$1.01$1.01$1.01FY 20254$4.10$4.10$4.10Q1 20261$1.03$1.03$1.03Q2 20261$1.04$1.04$1.04RDY Earnings Date and InformationDr. Reddy's Laboratories last released its earnings data on October 27th, 2023. The reported $1.07 earnings per share for the quarter, beating the consensus estimate of $0.88 by $0.19. The business had revenue of $832.16 million for the quarter, compared to analysts' expectations of $825.94 million. Dr. Reddy's Laboratories has generated $3.71 earnings per share over the last year ($3.71 diluted earnings per share) and currently has a price-to-earnings ratio of 18.8. Earnings for Dr. Reddy's Laboratories are expected to grow by 5.96% in the coming year, from $3.86 to $4.09 per share. Dr. Reddy's Laboratories has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, January 24th, 2024 based off prior year's report dates.Read More Dr. Reddy's Laboratories Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 1/24/2024Estimated)------- 10/27/2023Q2 2024$0.88$1.07+$0.19$1.07$825.94 million$832.16 million7/26/2023Q1 2024$0.71$1.03+$0.32$1.03$790.67 million$820.20 million5/10/2023Q4 2023$0.57$0.70+$0.13$0.70$763.37 million$766.00 million1/25/2023Q3 2023$0.60$0.91+$0.31$0.91$769.25 million$818.00 million10/28/2022Q2 2023$0.59$0.82+$0.23$0.82$763.28 million$775.00 million7/28/2022Q1 2023$0.58$0.90+$0.32$0.90$767.00 million$660.00 million Get the Latest News and Ratings for RDY and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Dr. Reddy's Laboratories and its competitors with MarketBeat's FREE daily newsletter. 5/19/2022Q4 2022-$0.53+$0.53$0.99-$717.00 million1/28/2022Q3 2022-$0.57+$0.57$0.57-$715.00 million10/29/2021Q3 2021$0.56$0.80+$0.24$0.80-$777.00 million7/27/2021Q2 2021$0.55$0.46($0.09)$0.46$685.22 million$662.00 million5/13/2021Q1 2021$0.51$0.46($0.05)$0.46-$646.00 million 1/29/2021Q3 2021-$0.41+$0.41$0.80-$675.00 million Dr. Reddy's Laboratories Earnings - Frequently Asked Questions When is Dr. Reddy's Laboratories's earnings date? Dr. Reddy's Laboratories has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, January 24th, 2024 based off last year's report dates. Learn more on RDY's earnings history. Did Dr. Reddy's Laboratories beat their earnings estimates last quarter? In the previous quarter, Dr. Reddy's Laboratories (NYSE:RDY) reported $1.07 earnings per share (EPS) to beat the analysts' consensus estimate of $0.88 by $0.19. Learn more on analysts' earnings estimate vs. RDY's actual earnings. How much revenue does Dr. Reddy's Laboratories generate each year? Dr. Reddy's Laboratories (NYSE:RDY) has a recorded annual revenue of $2.99 billion. How much profit does Dr. Reddy's Laboratories generate each year? Dr. Reddy's Laboratories (NYSE:RDY) has a recorded net income of $548 million. RDY has generated $3.71 earnings per share over the last four quarters. What is Dr. Reddy's Laboratories's price-to-earnings ratio? Dr. Reddy's Laboratories (NYSE:RDY) has a trailing price-to-earnings ratio of 18.81 and a forward price-to-earnings ratio of 18.08. The price/earnings-to-growth ratio is 2.06. What is Dr. Reddy's Laboratories's EPS forecast for next year? Dr. Reddy's Laboratories's earnings are expected to grow from $3.86 per share to $4.09 per share in the next year, which is a 5.96% increase. More Earnings Resources from MarketBeat Related Companies: Teva Pharmaceutical Industries Earnings Date Viatris Earnings Date Legend Biotech Earnings Date United Therapeutics Earnings Date Verona Pharma Earnings Date Sarepta Therapeutics Earnings Date Roivant Sciences Earnings Date Jazz Pharmaceuticals Earnings Date Catalent Earnings Date Karuna Therapeutics Earnings Date Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: The truth about Lululemon earnings: Suddenly in bearish crosshairOwn Dollar General? Hurry and take this advice before earningsEarnings propel Crowdstrike, cybersecurity sector, to new highsAlibaba is down more than 10% since earnings, now what?2 stocks that faded their price gaps after crushing earnings Hims & Hers earnings highlight expanded personalized treatmentsCan Kohl's keep its momentum after earnings dip? This page (NYSE:RDY) was last updated on 12/6/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Dr. Reddy's Laboratories Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.